Home Products The perils of the GLP-1 rebound and the off-ramp opportunity

The perils of the GLP-1 rebound and the off-ramp opportunity

by Newsroom



In fact, research shows that the weight tends to return more quickly after stopping anti-obesity medications than after completing behavioral programs—reinforcing concerns that transient GLP-1 use without sustained lifestyle modifications is likely to undermine long-term outcomes.

Here, dietary supplements may find opportunity in accepting a supporting role as part of a lifestyle approach, particularly if GLP-1 drug use is treated as a training window rather than a quick fix or lifetime commitment and contextualized within a continuum of metabolic myth cycles.

“This pattern of weight regain is not in any way exclusive to our new treatments,”…



Source link

You may also like

About Us

Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Health Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC